Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 523684, 8 pages
http://dx.doi.org/10.1155/2014/523684
Research Article

Epigallocatechin Gallate Attenuates Proliferation and Oxidative Stress in Human Vascular Smooth Muscle Cells Induced by Interleukin-1 via Heme Oxygenase-1

1Department of Respiratory Therapy, College of Medicine, and Department of Medical Research, Translational Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan
2School of Medicine, College of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
3Department of Neurosurgery, Chung Shan Medical University Hospital, Taichung 402, Taiwan
4Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 801, Taiwan
5Department of Internal Medicine, Department of Chest Surgery, Division of Cardiovascular Surgery and Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan

Received 13 June 2014; Accepted 8 August 2014; Published 7 September 2014

Academic Editor: Yung-Hsiang Chen

Copyright © 2014 Po-Len Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. M. Yatsu and M. Fisher, “Atherosclerosis: current concepts on pathogenesis and interventional therapies,” Annals of Neurology, vol. 26, no. 1, pp. 3–12, 1989. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Fisher, “Atherosclerosis: cellular aspects and potential interventions,” Cerebrovascular and Brain Metabolism Reviews, vol. 3, no. 2, pp. 114–133, 1991. View at Google Scholar · View at Scopus
  3. L. Liu, X. Xu, J. Li, X. Li, and W. Sheng, “Lentiviral-mediated shRNA silencing of PDE4D gene inhibits platelet-derived growth factor-induced proliferation and migration of rat aortic smooth muscle cells,” Stroke Research and Treatment, vol. 2011, Article ID 534257, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Patel, K. M. Channon, and E. McNeill, “The downstream regulation of chemokine receptor signalling: implications for atherosclerosis,” Mediators of Inflammation, vol. 2013, Article ID 459520, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Zimmermann, K. Li, and M. Zaczkiewicz, “C-reactive protein in human atherogenesis: facts and fiction,” Mediators of Inflammation, vol. 2014, Article ID 561428, 6 pages, 2014. View at Publisher · View at Google Scholar
  6. F. Strang and H. Schunkert, “C-reactive protein and coronary heart disease: all said—is not it?” Mediators of Inflammation, vol. 2014, Article ID 757123, 7 pages, 2014. View at Publisher · View at Google Scholar
  7. C.-P. Lin, Y.-H. Chen, H.-B. Leu et al., “Anti-inflammatory strategies for homocysteine-related cardiovascular disease,” Frontiers in Bioscience, vol. 14, no. 10, pp. 3836–3845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-P. Lin, F.-Y. Lin, P.-H. Huang et al., “Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation,” BioMed Research International, vol. 2013, Article ID 845037, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Maiolino, G. Rossitto, P. Caielli, and et al, “The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts,” Mediators of Inflammation, vol. 2013, Article ID 714653, 13 pages, 2013. View at Publisher · View at Google Scholar
  10. C. J. Liang, C. W. Lee, and H. C. Sung, “Ganoderma lucidum polysaccharides reduce lipopolysaccharide-induced interleukin-1 beta expression in cultured smooth muscle cells and in thoracic aortas in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 305149, 13 pages, 2014. View at Publisher · View at Google Scholar
  11. A. Bebes, F. Kovacs-Solyom, J. Prihoda et al., “Interleukin-1 receptors are differentially expressed in normal and psoriatic T cells,” Mediators of Inflammation, vol. 2014, Article ID 472625, 9 pages, 2014. View at Publisher · View at Google Scholar
  12. S.-J. Lin, H.-T. Yen, Y.-H. Chen, H.-H. Ku, F.-Y. Lin, and Y.-L. Chen, “Expression of interleukin-1β and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits,” Journal of Cellular Biochemistry, vol. 88, no. 4, pp. 836–847, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Bădulescu, C. Bădescu, M. Ciocoiu, and M. Bădescu, “Interleukin-1-beta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitus,” Mediators of Inflammation, vol. 2013, Article ID 169420, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Qamar and D. J. Rader, “Effect of interleukin 1β inhibition in cardiovascular disease,” Current Opinion in Lipidology, vol. 23, no. 6, pp. 548–553, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Bhardwaj and D. Khanna, “Green tea catechins: defensive role in cardiovascular disorders,” Chinese Journal of Natural Medicines, vol. 11, no. 4, pp. 345–353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. E. Szmitko and S. Verma, “Antiatherogenic potential of red wine: clinician update,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2023–H2030, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. P. V. A. Babu, H. Si, and D. Liu, “Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism,” Molecular Nutrition & Food Research, vol. 56, no. 9, pp. 1424–1432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. P.-L. Liu, J.-R. Tsai, A. L. Charles et al., “Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-κB pathway and subsequently downregulating expression of matrix metalloproteinases,” Molecular Nutrition and Food Research, vol. 54, no. 2, pp. S196–S204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-R. Tsai, H.-M. Wang, P.-L. Liu et al., “High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients,” Cellular Oncology, vol. 35, no. 6, pp. 461–471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. X.-H. Li, X. Gong, L. Zhang et al., “Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1,” Mediators of Inflammation, vol. 2013, Article ID 354087, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Grochot-Przeczek, J. Dulak, and A. Jozkowicz, “Haem oxygenase-1: non-canonical roles in physiology and pathology,” Clinical Science, vol. 122, no. 3, pp. 93–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. B.-M. Choi, D.-W. Lim, J.-A. Lee, S. S. Gao, D. Y. Kwon, and B.-R. Kim, “Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression,” Journal of Medicinal Food, vol. 11, no. 2, pp. 230–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. F.-Y. Lin, Y.-H. Chen, Y.-W. Lin et al., “The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2622–2629, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. F.-Y. Lin, Y.-H. Chen, J.-S. Tasi et al., “Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2630–2637, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-W. Chen, Y.-H. Chen, and S.-J. Lin, “Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor-α-stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways,” Free Radical Biology & Medicine, vol. 40, no. 5, pp. 817–826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-H. Chen, S.-J. Lin, H.-H. Ku et al., “Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-α-treated human aortic endothelial cells,” Journal of Cellular Biochemistry, vol. 82, no. 3, pp. 512–521, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. S.-J. Lin, T.-H. Yang, Y.-H. Chen et al., “Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1 β expression after balloon injury in cholesterol-fed rabbits in vivo,” Journal of Cellular Biochemistry, vol. 85, no. 3, pp. 572–582, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. P.-L. Liu, Y.-L. Chen, Y.-H. Chen, S.-J. Lin, and Y. R. Kou, “Wood smoke extract induces oxidative stress-mediated caspase-independent apoptosis in human lung endothelial cells: role of AIF and EndoG,” The American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 289, no. 5, pp. L739–L749, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-W. Chen, Y.-H. Chen, F.-Y. Lin, Y.-L. Chen, and S.-J. Lin, “Ginkgo biloba extract inhibits tumor necrosis factor-α-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 9, pp. 1559–1566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-H. Chen, F.-Y. Lin, P.-L. Liu et al., “Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats,” Archives of Pharmacal Research, vol. 32, no. 2, pp. 221–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Zheng, A. Morris, M. Sunkara, J. Layne, M. Toborek, and B. Hennig, “Epigallocatechin-gallate stimulates NF-E2-related factor and heme oxygenase-1 via caveolin-1 displacement,” Journal of Nutritional Biochemistry, vol. 23, no. 2, pp. 163–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Li, Y.-H. Chen, T.-J. Liu et al., “Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells,” Circulation Research, vol. 93, no. 12, pp. 1202–1209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole et al., “Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11908–11913, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. R. M. Starke, N. Chalouhi, M. S. Ali et al., “The role of oxidative stress in cerebral aneurysm formation and rupture,” Current Neurovascular Research, vol. 10, no. 3, pp. 247–255, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Johnson, S. Bryant, and A. L. Huntley, “Green tea and green tea catechin extracts: an overview of the clinical evidence,” Maturitas, vol. 73, no. 4, pp. 280–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Khan and H. Mukhtar, “Tea and health: studies in humans,” Current Pharmaceutical Design, vol. 19, no. 34, pp. 6141–6147, 2013. View at Google Scholar
  37. C. C. Wu, M. C. Hsu, C. W. Hsieh, J. B. Lin, P. H. Lai, and B. S. Wung, “Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways,” Life Sciences, vol. 78, no. 25, pp. 2889–2897, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Zheng, M. Toborek, and B. Hennig, “Epigallocatechin gallate-mediated protection against tumor necrosis factor-α-induced monocyte chemoattractant protein-1 expression is heme oxygenase-1 dependent,” Metabolism: Clinical and Experimental, vol. 59, no. 10, pp. 1528–1535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Pullikotil, H. Chen, R. Muniyappa et al., “Epigallocatechin gallate induces expression of heme oxygenase-1 in endothelial cells via p38 MAPK and Nrf-2 that suppresses proinflammatory actions of TNF-α,” Journal of Nutritional Biochemistry, vol. 23, no. 9, pp. 1134–1145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-K. Na, E.-H. Kim, J.-H. Jung, H.-H. Lee, J.-W. Hyun, and Y.-J. Surh, “(-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells,” Archives of Biochemistry and Biophysics, vol. 476, no. 2, pp. 171–177, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Romeo, M. Intrieri, V. D'Agata et al., “The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress,” Journal of the American College of Nutrition, vol. 28, pp. 492S–499S, 2009. View at Google Scholar · View at Scopus
  42. K. Sahin, M. Tuzcu, H. Gencoglu et al., “Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats,” Life Sciences, vol. 87, no. 7-8, pp. 240–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Kakuta, M. Okumi, Y. Isaka et al., “Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration,” Transplant International, vol. 24, no. 5, pp. 514–522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M.-H. Kweon, V. M. Adhami, J.-S. Lee, and H. Mukhtar, “Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate,” The Journal of Biological Chemistry, vol. 281, no. 44, pp. 33761–33772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. I.-T. Lee, C.-C. Lin, C.-Y. Lee, P.-W. Hsieh, and C.-M. Yang, “Protective effects of (-)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition,” Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 124–136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. H. You, L. Wei, W. L. Sun et al., “The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats,” International Journal of Molecular Medicine, vol. 34, no. 1, pp. 92–102, 2014. View at Google Scholar
  47. M. Zhang, B. H. Zhang, L. Chen, and W. An, “Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation,” Cell Research, vol. 12, no. 2, pp. 123–132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Jiang, R. Jiang, X. Zhu, X. Zhang, and Z. Zhan, “Genipin Inhibits TNF-α-Induced Vascular Smooth Muscle Cell Proliferation and Migration via Induction of HO-1,” PLoS ONE, vol. 8, no. 8, Article ID e74826, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. R. R. Campos, “Oxidative stress in the brain and arterial hypertension,” Hypertension Research, vol. 32, no. 12, pp. 1047–1048, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. J. E. Kim, Y. J. Kang, K. Y. Lee, and H. C. Choi, “Isoproterenol inhibits angiotensin II-stimulated proliferation and reactive oxygen species production in vascular smooth muscle cells through heme oxygenase-1,” Biological and Pharmaceutical Bulletin, vol. 32, no. 6, pp. 1047–1052, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. R. M. Ogborne, S. A. Rushworth, and M. A. O'Connell, “Epigallocatechin activates haem oxygenase-1 expression via protein kinase Cδ and Nrf2,” Biochemical and Biophysical Research Communications, vol. 373, no. 4, pp. 584–588, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. C. J. Sherr, “Cancer cell cycles,” Science, vol. 274, no. 5293, pp. 1672–1677, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. Y.-H. Chen, S.-J. Lin, Y.-L. Chen, P.-L. Liu, and J.-W. Chen, “Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules,” Cardiovascular and Hematological Disorders—Drug Targets, vol. 6, no. 4, pp. 279–304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Fortuño, G. San José, M. U. Moreno, J. Díez, and G. Zalba, “Oxidative stress and vascular remodelling,” Experimental Physiology, vol. 90, no. 4, pp. 457–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. E. O. Farombi and Y.-J. Surh, “Heme oxygenase-1 as a potential therapeutic target for hepatoprotection,” Journal of Biochemistry and Molecular Biology, vol. 39, no. 5, pp. 479–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. H. S. Marinho, C. Real, L. Cyrne, H. Soares, and F. Antunes, “Hydrogen peroxide sensing, signaling and regulation of transcription factors,” Redox Biology, vol. 2, pp. 535–562, 2014. View at Publisher · View at Google Scholar